Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Other Working Capital Changes (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Other Working Capital Changes for 7 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 1295.15% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 1516.81% year-over-year, with the annual reading at $1.7 million for FY2025, 1516.81% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $2.5 million at Strata Critical Medical, up from -$3.1 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $3.9 million in Q2 2022, with the low at -$3.1 million in Q3 2025.
  • Average Other Working Capital Changes over 5 years is $307526.3, with a median of $848000.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes surged 9267.57% in 2021, then plummeted 330.26% in 2022.
  • Over 5 years, Other Working Capital Changes stood at $1.3 million in 2021, then crashed by 330.26% to -$3.0 million in 2022, then soared by 67.58% to -$987000.0 in 2023, then surged by 79.13% to -$206000.0 in 2024, then soared by 1295.15% to $2.5 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $2.5 million, -$3.1 million, and $999000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.